Vuity contracts the iris sphincter muscle, constricting the pupil to improve near and intermediate visual acuity. The Food and Drug Administration (FDA) has approved the supplemental New Drug ...
Please provide your email address to receive an email when new articles are posted on . A second dose of Vuity 3 to 6 hours after the first dose may extend the effect for up to 9 hours. The most ...
VUITY is the first and only eye drop to treat presbyopia, or age-related blurry near vision, in adults and is FDA-approved for once-daily administration In the VIRGO trial evaluating twice-daily ...
VUITY, an FDA-approved eye drop for presbyopia, has significant market potential given the growing aging population. With an estimated 128 million Americans affected by presbyopia, VUITY offers a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback